Sunday, July 20, 2025 11:41 PM

Tag: BioCryst Pharmaceuticals

BioCryst Pharmaceuticals ($BCRX) to receive $250M upfront plus $14M milestones from Neopharmed Gentili

NewsDesk CD -
BioCryst Pharmaceuticals, Inc. (BCRX) has entered into a definitive agreement to sell its European ORLADEYO® (berotralstat) business to Neopharmed Gentili for up to $264...
Our platform offers actionable news and data on events that could sway financial markets. At Catalyst DAILY, we monitor a wide variety of market catalysts, which are essential events or announcements that can trigger significant price movements in stocks, currencies, or entire sectors.

OUR WEBSITE STRICTLY PROHIBITS ANY FORM OF PROMOTION OR TOUTING
Contact us: info@catalystdaily.com
© Catalyst Daily 2025